ERM
Ergotamine
Created: | 2013-01-23 |
Last modified: | 2013-03-13 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 78 |
Chiral Atom Count | 6 |
Bond Count | 85 |
Aromatic Bond Count | 16 |
Chemical Component Summary | |
---|---|
Name | Ergotamine |
Systematic Name (OpenEye OEToolkits) | n/a |
Formula | C33 H35 N5 O5 |
Molecular Weight | 581.661 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | O=C6N7C(C(=O)N1CCCC1C7(O)OC6(NC(=O)C5C=C4c2cccc3c2c(cn3)CC4N(C)C5)C)Cc8ccccc8 |
SMILES | CACTVS | 3.370 | CN1C[CH](C=C2[CH]1Cc3c[nH]c4cccc2c34)C(=O)N[C]5(C)O[C]6(O)[CH]7CCCN7C(=O)[CH](Cc8ccccc8)N6C5=O |
SMILES | OpenEye OEToolkits | 1.7.6 | CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)Cc4ccccc4)NC(=O)C5CN(C6Cc7c[nH]c8c7c(ccc8)C6=C5)C |
Canonical SMILES | CACTVS | 3.370 | CN1C[C@@H](C=C2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C5=O |
Canonical SMILES | OpenEye OEToolkits | 1.7.6 | C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@H]5CN([C@@H]6Cc7c[nH]c8c7c(ccc8)C6=C5)C |
InChI | InChI | 1.03 | InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1 |
InChIKey | InChI | 1.03 | XCGSFFUVFURLIX-VFGNJEKYSA-N |
Drug Info: DrugBank
DrugBank ID | DB00696 |
---|---|
Name | Ergotamine |
Groups | approved |
Description | A vasoconstrictor found in ergot of Central Europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of migraine disorders. |
Synonyms |
|
Brand Names |
|
Indication | For use as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants, or so called "histaminic cephalalgia". |
Categories |
|
ATC-Code |
|
CAS number | 113-15-5 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
5-hydroxytryptamine receptor 1D | MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITL... | unknown | agonist |
5-hydroxytryptamine receptor 1B | MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKV... | unknown | agonist |
5-hydroxytryptamine receptor 2A | MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSE... | unknown | agonist |
Alpha-1A adrenergic receptor | MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILS... | unknown | partial agonist |
Alpha-1B adrenergic receptor | MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGL... | unknown | partial agonist |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL442 |
PubChem | 8223 |
ChEMBL | CHEMBL442 |
ChEBI | CHEBI:64318 |
CCDC/CSD | FETGAN |